The Scientist

» acute lymphoblastic leukemia

Most Recent

image: First CAR T-Cell Therapy Approved in U.S.

First CAR T-Cell Therapy Approved in U.S.

By | August 30, 2017

The genetically modified blood cells will be used for patients with a type of acute lymphoblastic leukemia, when other treatments fail.

1 Comment

image: FDA Votes Yes on CAR T-Cell Therapy

FDA Votes Yes on CAR T-Cell Therapy

By | July 13, 2017

A Food and Drug Administration advisory panel unanimously calls for agency approval of the cell therapy for the treatment of resistant leukemia. 

0 Comments

image: Gene Editing Treats Leukemia

Gene Editing Treats Leukemia

By | November 6, 2015

One-year-old Layla Richards has remained cancer-free months after receiving an experimental gene editing therapy.

0 Comments

image: Tumor-Targeting T Cells Engineered

Tumor-Targeting T Cells Engineered

By | August 11, 2013

Scientists genetically modify T cells derived from pluripotent stem cells to attack lymphatic tumors.

0 Comments

image: Immune System Versus Cancer

Immune System Versus Cancer

By | April 10, 2013

Engineering the immune system to overcome tumor evasion strategies was a hot topic at this week’s AACR meeting, with researchers discussing several new approaches.

0 Comments

image: Leukemia Linked to Changes in Womb

Leukemia Linked to Changes in Womb

By | April 10, 2013

Genetic changes that may initiate childhood leukemia could originate while the baby is still in utero.

0 Comments

image: Contributors

Contributors

By | April 1, 2013

Meet some of the people featured in the April 2013 issue of The Scientist.

0 Comments

image: Up, Up, and Array

Up, Up, and Array

By | April 1, 2013

By scrutinizing gene expression profiles instead of individual oncogenes, Todd Golub launched a powerful platform for diagnosing, classifying, and treating cancer.

1 Comment

Popular Now

  1. Can Young Stem Cells Make Older People Stronger?
  2. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  3. Two Dozen House Republicans Do an About-Face on Tuition Tax
  4. CRISPR to Debut in Clinical Trials